Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

337 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Gene delivery to the corneal endothelium.
George AJ, Arancibia-Cárcamo CV, Awad HM, Comer RM, Fehevari Z, King WJ, Kadifachi M, Hudde T, Kerouedan-Lebossé C, Mirza F, Barbaros Oral H, Rayner SA, Tan PH, Tay E, Larkin DF. George AJ, et al. Among authors: mirza f. Am J Respir Crit Care Med. 2000 Oct;162(4 Pt 2):S194-200. doi: 10.1164/ajrccm.162.supplement_3.15tac11. Am J Respir Crit Care Med. 2000. PMID: 11029394 Review.
High avidity antigen-specific CTL identified by CD8-independent tetramer staining.
Choi EM, Chen JL, Wooldridge L, Salio M, Lissina A, Lissin N, Hermans IF, Silk JD, Mirza F, Palmowski MJ, Dunbar PR, Jakobsen BK, Sewell AK, Cerundolo V. Choi EM, et al. Among authors: mirza f. J Immunol. 2003 Nov 15;171(10):5116-23. doi: 10.4049/jimmunol.171.10.5116. J Immunol. 2003. PMID: 14607910
Anti-CD8 antibodies can inhibit or enhance peptide-MHC class I (pMHCI) multimer binding: this is paralleled by their effects on CTL activation and occurs in the absence of an interaction between pMHCI and CD8 on the cell surface.
Wooldridge L, Hutchinson SL, Choi EM, Lissina A, Jones E, Mirza F, Dunbar PR, Price DA, Cerundolo V, Sewell AK. Wooldridge L, et al. Among authors: mirza f. J Immunol. 2003 Dec 15;171(12):6650-60. doi: 10.4049/jimmunol.171.12.6650. J Immunol. 2003. PMID: 14662868
Recombinant modified vaccinia Ankara primes functionally activated CTL specific for a melanoma tumor antigen epitope in melanoma patients with a high risk of disease recurrence.
Smith CL, Dunbar PR, Mirza F, Palmowski MJ, Shepherd D, Gilbert SC, Coulie P, Schneider J, Hoffman E, Hawkins R, Harris AL, Cerundolo V. Smith CL, et al. Among authors: mirza f. Int J Cancer. 2005 Jan 10;113(2):259-66. doi: 10.1002/ijc.20569. Int J Cancer. 2005. PMID: 15386406 Clinical Trial.
HLA-A*0201, HLA-A*1101, and HLA-B*0702 transgenic mice recognize numerous poxvirus determinants from a wide variety of viral gene products.
Pasquetto V, Bui HH, Giannino R, Banh C, Mirza F, Sidney J, Oseroff C, Tscharke DC, Irvine K, Bennink JR, Peters B, Southwood S, Cerundolo V, Grey H, Yewdell JW, Sette A. Pasquetto V, et al. Among authors: mirza f. J Immunol. 2005 Oct 15;175(8):5504-15. doi: 10.4049/jimmunol.175.8.5504. J Immunol. 2005. PMID: 16210659
Resistance to cosmetic botulinum toxin A: A 15-patient case series across 12 sites.
Wambier CG, Mirza FN, Wambier SPF, Bertucci V, Carruthers J, Kaufman J, Martin J, Sterling JB, Brasileiro F, Marçon C, Brown AJ, Rosenberg M, Guadanhim LRS, Hexsel D. Wambier CG, et al. Among authors: mirza fn. JAAD Int. 2024 Sep 28;18:5-7. doi: 10.1016/j.jdin.2024.08.021. eCollection 2025 Feb. JAAD Int. 2024. PMID: 39553483 Free PMC article. No abstract available.
337 results